John P. Feighner

12.3k total citations · 2 hit papers
84 papers, 8.9k citations indexed

About

John P. Feighner is a scholar working on Pharmacology, Psychiatry and Mental health and Experimental and Cognitive Psychology. According to data from OpenAlex, John P. Feighner has authored 84 papers receiving a total of 8.9k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Pharmacology, 49 papers in Psychiatry and Mental health and 25 papers in Experimental and Cognitive Psychology. Recurrent topics in John P. Feighner's work include Treatment of Major Depression (52 papers), Electroconvulsive Therapy Studies (24 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (23 papers). John P. Feighner is often cited by papers focused on Treatment of Major Depression (52 papers), Electroconvulsive Therapy Studies (24 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (23 papers). John P. Feighner collaborates with scholars based in United States, Colombia and Ireland. John P. Feighner's co-authors include William F. Boyer, Jay B. Cohn, Jonathan Cole, James M. Ferguson, Charles Merideth, K. Fredricson Overø, John A. Ascher, Louis F. Fabre, R M Ferris and Peter Martin and has published in prestigious journals such as JAMA, American Journal of Psychiatry and Neurology.

In The Last Decade

John P. Feighner

83 papers receiving 7.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnostic Criteria for Use in Psychiatric Research

1972 4.5k citations John P. Feighner profile →
Bupropion: a review of its mechanism of antidepressant activity.

1995 561 citations John P. Feighner et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John P. Feighner United States	37	3.8k	2.7k	2.2k	1.8k	1.4k	84	8.9k
H. M. van Praag Netherlands	56	2.7k 0.7×	1.9k 0.7×	2.3k 1.0×	1.4k 0.7×	3.1k 2.3×	258	9.5k
David L. Dünner United States	60	6.3k 1.6×	3.2k 1.2×	3.5k 1.6×	3.1k 1.7×	1.1k 0.8×	266	13.6k
Lars von Knorring Sweden	52	2.9k 0.7×	1.4k 0.5×	4.0k 1.8×	1.3k 0.7×	1.1k 0.8×	256	9.4k
John F. Greden United States	49	2.5k 0.6×	2.0k 0.7×	2.4k 1.1×	1.8k 1.0×	838 0.6×	192	9.0k
Julien Mendlewicz Belgium	59	4.7k 1.2×	3.0k 1.1×	2.5k 1.1×	2.6k 1.4×	1.7k 1.3×	386	13.1k
Jan Fawcett United States	52	3.1k 0.8×	2.5k 0.9×	3.1k 1.4×	2.1k 1.2×	793 0.6×	208	8.6k
Isabella Heuser Germany	62	3.6k 0.9×	1.9k 0.7×	2.0k 0.9×	1.8k 1.0×	1.2k 0.9×	296	12.6k
Alan J. Gelenberg United States	49	3.5k 0.9×	2.7k 1.0×	1.8k 0.8×	1.7k 0.9×	628 0.5×	158	8.7k
Mario Maj Italy	56	4.5k 1.2×	1.5k 0.6×	3.9k 1.8×	1.4k 0.8×	865 0.6×	301	11.7k
Janusz Rybakowski Poland	53	5.9k 1.5×	1.3k 0.5×	1.6k 0.7×	1.0k 0.6×	1.3k 0.9×	466	11.3k

Countries citing papers authored by John P. Feighner

Since Specialization

Citations

This map shows the geographic impact of John P. Feighner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. Feighner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. Feighner more than expected).

Fields of papers citing papers by John P. Feighner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John P. Feighner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. Feighner. The network helps show where John P. Feighner may publish in the future.

Co-authorship network of co-authors of John P. Feighner

This figure shows the co-authorship network connecting the top 25 collaborators of John P. Feighner. A scholar is included among the top collaborators of John P. Feighner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John P. Feighner. John P. Feighner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Feighner, John P., et al.. (2008). Clinical effect of nemifitide, a novel pentapeptide antidepressant, in the treatment of severely depressed refractory patients. International Clinical Psychopharmacology. 23(1). 29–35. 3 indexed citations

Feighner, John P., et al.. (2003). Clinical effectiveness of nemifitide, a novel pentapeptide antidepressant, in depressed outpatients: comparison of follow-up re-treatment with initial treatment. The International Journal of Neuropsychopharmacology. 6(3). 207–213. 7 indexed citations

Feighner, John P., et al.. (2002). Clinical pharmacokinetic studies with INN 00835 (Nemifitide), a novel pentapeptide antidepressant. Biopharmaceutics & Drug Disposition. 23(1). 33–39. 5 indexed citations

Feighner, John P., et al.. (2001). Citalopram Treatment of Fluoxetine Nonresponders. The Journal of Clinical Psychiatry. 62(9). 683–687. 31 indexed citations

Feighner, John P., et al.. (2001). Double-blind, placebo-controlled study of INN 00835 (netamiftide) in the treatment of outpatients with major depression. International Clinical Psychopharmacology. 16(6). 345–352. 13 indexed citations

Kelly, John, G. Nicolau, Anna Redmond, et al.. (1999). The effect of treatment with a new antidepressant, INN 00835, on platelet serotonin uptake in depressed patients. Journal of Affective Disorders. 55(2-3). 231–235. 7 indexed citations

Feighner, John P.. (1999). Mechanism of action of antidepressant medications.. PubMed. 60 Suppl 4. 4–11; discussion 12. 243 indexed citations

Feighner, John P., et al.. (1998). Efficacy of once-daily venlafaxine extended release (XR) for symptoms of anxiety in depressed outpatients. Journal of Affective Disorders. 47(1-3). 55–62. 49 indexed citations

Rudolph, Richard L., Louis F. Fabre, John P. Feighner, et al.. (1998). A Randomized, Placebo-Controlled, Dose-Response Trial of Venlafaxine Hydrochloride in the Treatment of Major Depression. The Journal of Clinical Psychiatry. 59(3). 116–122. 109 indexed citations

10.

Feighner, John P. & William F. Boyer. (1996). Selective serotonin re-uptake inhibitors : advances in basic research and clinical practice. 48 indexed citations

11.

Ferguson, James M., Lynn Cunningham, Charles Merideth, et al.. (1994). Bupropion in Tricyclic Antidepressant Nonresponders with Unipolar Major Depressive Disorder. Annals of Clinical Psychiatry. 6(3). 153–160. 18 indexed citations

12.

Feighner, John P., Jay B. Cohn, Louis F. Fabre, et al.. (1993). A study comparing paroxetine placebo and imipramine in depressed patients. Journal of Affective Disorders. 28(2). 71–79. 67 indexed citations

13.

Claghorn, James L. & John P. Feighner. (1993). A Double-Blind Comparison of Paroxetine With Imipramine in the Long-Term Treatment of Depression. Journal of Clinical Psychopharmacology. 13(Supplement 2). 23S???27S–23S???27S. 42 indexed citations

14.

Feighner, John P. & William F. Boyer. (1991). The diagnosis of depression. Wiley eBooks. 4 indexed citations

15.

Dunbar, G. C., Jay B. Cohn, Louis F. Fabre, et al.. (1991). A Comparison of Paroxetine, Imipramine and Placebo in Depressed Out-patients. The British Journal of Psychiatry. 159(3). 394–398. 151 indexed citations

16.

Feighner, John P., et al.. (1990). A Controlled Trial of Adinazolam versus Desipramine in Geriatric Depression. International Clinical Psychopharmacology. 5(3). 227–232. 12 indexed citations

17.

Feighner, John P., William F. Boyer, Charles Merideth, & G. GORDON HENDRICKSON. (1989). A Double-Blind Comparison of Fluoxetine, Imipramine and Placebo in Outpatients with Major Depression. International Clinical Psychopharmacology. 4(2). 127–134. 47 indexed citations

18.

Feighner, John P. & William F. Boyer. (1989). Serotonin-IA Anxiolytics: An Overview. Psychopathology. 22(1). 21–26. 103 indexed citations

19.

Feighner, John P., et al.. (1989). A Placebo-controlled Inpatient Comparison of Fluvoxamine Maleate and Imipramine in Major Depression. International Clinical Psychopharmacology. 4(3). 239–244. 66 indexed citations

20.

Feighner, John P.. (1984). Trazodone in Major Affective Disorders. Psychopathology. 17(2). 15–23. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact